Magzter Gold (Sitewide CA)
Russian Life (Digital)

Russian Life (Digital)

1 Issue, March/April 2021

Also available on
MagzterGold logo

Get unlimited access to this article, this issue, + back issues & 9,000+ other magazines and newspapers.

Starting at $14.99/month

Choose a Plan
7-Day No Questions Asked Refund Guarantee.
Learn more

Sputnik V: First Place or Long Shot?

Sputnik V: First Place or Long Shot?
As the historic Battle of Stalingrad raged in 1942, Zinaida Yermolyeva, a 43-year-old Soviet microbiologist, was assigned to help the city overcome a cholera outbreak that was proving nearly as fatal to Soviet troops as the German bombardments. After early experiments on herself, Yermolyeva would go on to develop an effective way of treating drinking water that the Red Army was sourcing from the Volga River, as well as an eventual antibiotic against cholera, diphtheria and typhoid. Her efforts proved critical in protecting Soviet soldiers from infectious diseases at that fateful battle and – eventually – defeating the Nazi military juggernaut. Howard Florey, the inventor of penicillin, praised her as the creator of an antibiotic equal to his own.
Today, Russians are more skeptical about healthcare solutions promoted by their government: in a survey conducted in December, only 38 percent said they were willing to take the country’s domestically-made coronavirus vaccine, Sputnik V (named after the first man-made satellite sent into space), despite Russia having the world’s fourth-largest outbreak – over 3.7 million cases. After a much-publicized August rollout of “the world’s first registered COVID vaccine,” the bullhorns of Russian state media lapsed into an awkward silence. The vaccine was available, it was safe (apparently), cases had begun to tick upwards in a second autumn wave, the government was reluctant to shutter businesses in another lockdown, and… there was no news about how to get inoculated.
President Vladimir Putin had announced on TV that mass inoculations would finally be widely available after having given priority to frontline workers. The results had been mixed: a few weeks ago, the developers of Sputnik V claimed that 1.5 million Russians had received a dose of the vaccine. These figures were subject to criticism, and rumors of healthcare workers being pressured into taking the vaccine didn’t help the cause. Since then, reliable data has been hard to find, with the best estimates suggesting that 0.69 doses of the vaccine have been administered per 100 people in Russia, considerably behind Israel (56.28), the United States (9.4) and France (2.25).
Leonid Nezlin, a 65-year-old neurobiologist in Moscow, is skeptical of Sputnik V’s declared effectiveness. “Vladimir Putin has advertised it, but hasn’t been vaccinated himself. Besides, we still haven’t seen the results of the Phase 3 trials. It appears suspicious,” he said. Nezlin added he would take Sputnik V if it is registered in the US and EU, so that he could travel there. The suspicion spreads across generational lines: Yekaterina Makhnovskaya, a 31-year-old university lecturer, put it succinctly: “The vaccine is not tested; there’s not enough data. Who knows what kind of reaction your body will have in a year’s time?” She is waiting until her doctor gets the jab before inoculating her family.
[https://magarticles.magzter.com/articles/4369/610362/6049e56335308/1615455457673.jpg]
Public trust in the vaccine has not been the only barrier to achieving herd immunity. My girlfriend, who is Austrian, responded to a posting in a Facebook group for Moscow expats. A national TV channel was eager to show foreigners taking the Sputnik V vaccine. The following morning we showed up at a glitzy skyscraper in Moscow’s business district. The vaccine was being distributed via a remarkably efficient national network of online and municipal state service centers established years earlier, and we had been assigned to one of its flagship offices that offer free health screenings in addition to everything from registering property to signing up for health insurance. After filling out consent and health background forms, we waited in line for 10 minutes. The jab itself took less than two minutes; we were both completely asymptomatic and went to our respective offices after spending the mandatory half hour in the waiting room (a precautionary procedure in case of anaphylactic shock).
“You actually trust this Russian vaccine?” was the most common reaction I got after revealing I had gotten my first jab of Sputnik V in late January. “I trust the vaccine as much as I trust anything in our post-truth world,” I replied. I’ve seen no credible evidence debunking the ...
You're reading a preview of
Russian Life (Digital) - 1 Issue, March/April 2021

DiscountMags is a licensed distributor (not a publisher) of the above content and Publication through Magzter Inc. Accordingly, we have no editorial control over the Publications. Any opinions, advice, statements, services, offers or other information or content expressed or made available by third parties, including those made in Publications offered on our website, are those of the respective author(s) or publisher(s) and not of DiscountMags. DiscountMags does not guarantee the accuracy, completeness, truthfulness, or usefulness of all or any portion of any publication or any services or offers made by third parties, nor will we be liable for any loss or damage caused by your reliance on information contained in any Publication, or your use of services offered, or your acceptance of any offers made through the Service or the Publications. For content removal requests, please contact Magzter.

© 1999 – 2025 DiscountMags.com All rights reserved.